Clinical Oncology
Current issue
Most read in this issue
- Treatment of retroperitoneal fibrosis with rituximab, cyclophosphamide and dexamethasone, followed by rituximab and dexamethasone maintenance, achieved disappearance of pathological PET accumulation of FDG and regression of fibrotic masses after 4 months of therapy and the patient is still in complete remission after 3 years. A case report and iteraure review.
- Gemcitabine/nab-paclitaxel in first line treatment of advanced pancreatic cancer – head-to-head comparison with the mFOLFIRINOX regimen
- The guidelines for clinical practice for carriers of germline mutations in the Lynch syndrome predisposition genes MLH1, MSH2, MSH6, PMS2 and large deletions of EPCAM (4.2024)
- Viral pneumonia in a patient treated with pembrolizumab – similarity with immune-related pneumonitis
Journal archive
2024
2023
2022
2021
2020
Issue 6
Issue Supplementum 3
Issue Supplementum - 2
Issue Suppl 1
Issue 4
Issue 5
Issue 3
Issue 2
Issue 1
2019
Issue 6
Issue Supplementum 3
Issue 5
Issue 4
Issue Supplementum2
Issue 3
Issue 2
Issue Supplementum1
Issue 1
2018
2017
Issue 6
Issue Supplementum3
Issue Online only
Issue 5
Issue 4
Issue Supplementum2
Issue 3
Issue Supplementum1
Issue 2
Issue 1
2016
Issue 6
Issue 5
Issue Supplementum 4
Issue Supplementum 3
Issue 4
Issue 3
Issue 2
Issue 1
Issue Supplementum 1
- Hodnocení klinického stadia a léčebné odpovědi u maligních lymfomů – doporučení Kooperativní lymfomové skupiny na základě revidovaných kritérií z roku 2014 (Luganská klasifikace)
- SBORNÍK ABSTRAKT XL. brněnské onkologické dny a XXX. konference pro nelékařské zdravotnické pracovníky 27.–29. 4. 2016, Brno
2015
Issue 6
Issue Supplementum 4
Issue Supplementum 3
Issue 5
Issue 4
Issue Supplementum 2
Issue 3
Issue Supplementum 1
Issue 2
Issue 1